Contact

Interventional Cardiology

Home / Specialità / Cardiovascular / Interventional Cardiology

Gada Italia supports interventional cardiology professionals with a wide range of advanced solutions designed to ensure precise, safe, and effective procedures.

From vascular access to structural defect closure, coronary intervention devices to pulmonary embolism management, we provide cutting-edge technologies that improve clinical outcomes and optimize minimally invasive procedures.

Our expertise in the field allows us to offer state-of-the-art tools that aid in the diagnosis and treatment of complex cardiovascular diseases, reducing patient risks and facilitating the work of specialists.

1

Wide range of specialist solutions

2

Cutting-edge technologies

3

Optimization of procedural flows

4

Reducing risks for the patient

5

Support for the diagnosis and treatment of complex diseases

6

Extensive experience in the sector

Discover in detail our solutions for every area of ​​interventional cardiology.

/ product lines

Discover our product lines

Diagnostics
PCI (Percutaneous Coronary Intervention)
Interventional treatment of refractory angina
Devices for Venous Thromboembolism
Mechanical Circulatory Support
Pulmonary Artery Denervation
Structural Heart Solutions

Introducers

  • Femoral Introducers: devices for transfemoral vascular access.
  • RADIFOCUS™ Introducer II Mcoat™: radial introducer with hydrophilic coating to minimize friction and improve navigability. This technology enhances vascular navigation, ensuring smoother, safer, and more comfortable interventional procedures.
  • Slender: low-profile radial introducer designed for patients with small vessels.

Radial compression system

  • TR Band™: radial artery compression device for post-procedure hemostasis, with precise pressure control to ensure safety and patient comfort.

Diagnostic catheters

  • Optitorque™: high-performance coronary diagnostic catheter optimized for complex anatomies.
  • Outlook™: diagnostic catheter with excellent trackability and support.

Guiding catheters

  • Heartrail™: guiding catheter with robust, flexible structure for stable coronary support.
  • Climber™: guiding catheter designed to provide additional support in complex anatomies.

Coronary guidewires

  • Runthrough™: coronary guidewire balancing pushability and flexibility for complex interventions and tortuous vessels.

Coronary microcatheters

  • Finecross™ MG: coronary microcatheter combining high crossing ability and guidewire support, ideal for complex cases such as tortuous vessels, chronic total occlusions (CTO), and bifurcations.
  • Finecross™ M3: evolution of the MG with increased trackability and support.

PTCA balloons

  • Accuforce™: non-compliant PTCA balloon catheter offering optimal balance between high pressure and durability, ensuring accurate dilation and advanced deliverability for the treatment of complex coronary lesions.
  • Ryurei™: semi-compliant PTCA balloon catheter offering superior crossing capability thanks to a reduced distal profile and Terumo’s Mcoat™ hydrophilic coating, facilitating access to difficult lesions.

Aspiration catheter

  • Eliminate™: aspiration catheter for the removal of coronary thrombi.

Coronary stents

  • Ultimaster™ Tansei™: sirolimus-eluting stent with biodegradable polymer, optimized for coronary support and vascular healing.
  • Ultimaster™ Nagomi™: sirolimus-eluting coronary stent system with biodegradable polymer, designed to offer excellent conformability and optimal vessel support, improving clinical outcomes in patients undergoing percutaneous coronary interventions.

Among our advanced solutions, we include innovative devices such as Reducer, designed to ensure minimally invasive procedures and optimal clinical results.

Shockwave Reducer: a percutaneous, hourglass-shaped device that creates controlled narrowing of the coronary sinus, increasing retrograde pressure and improving myocardial perfusion in ischemic areas. This helps reduce symptoms of refractory angina, providing an effective, minimally invasive treatment option.

These state-of-the-art devices represent groundbreaking solutions in the field of structural heart interventions, significantly improving patient quality of life through safe and effective procedures.

We offer advanced mechanical thrombectomy systems for percutaneous treatment, ideal for safely and effectively treating deep vein thrombosis (DVT) and pulmonary embolism. Our solutions enable rapid thrombus removal, improving patient symptoms and their quality of life. Among our advanced percutaneous mechanical thrombectomy systems for treating pulmonary embolism and deep vein thrombosis, we offer devices such as FlowTriever and ClotTriever by Inari Medical:
  • FlowTriever System: A percutaneous device, designed for mechanical thrombus removal in pulmonary arteries, in a single session without the use of thrombolytics. It reduces the risk of bleeding and intensive care unit (ICU) stay times, and improving quickly the hemodynamics parameters.
  • ClotTriever System: a percutaneous device designed for mechanical thrombus removal in peripheral veins, indicated for deep vein thrombosis (DVT) treatment. It allows complete thrombus removal in a single session without the use of thrombolytics, rapidly improving symptoms and reducing the risk of long-term complications.
These devices offer effective options for managing thromboembolic diseases, contributing to better clinical outcomes and enhanced quality of life for patients.

Our mechanical circulatory support systems provide temporary cardiac assistance during or after complex cardiac procedures to prevent or treat hemodynamic instability or cardiogenic shock. These systems help stabilize the patient’s condition and improve cardiac function.

Among our solutions, the Impella CP® with SmartAssist® catheter is a percutaneous device that delivers up to 4.3 L/min additional blood flow to the circulation, making it ideal for patients in cardiogenic shock or at risk for hemodynamic instability, i.e. during high-risk PCI. The SmartAssist® technology enables continuous monitoring and optimal positioning.

  • Minimally invasive access

  • Immediate hemodynamic stability

  • Direct left-ventricular unloading

We offer an innovative therapeutic approach for the treatment of pulmonary hypertension. The Pulnovo® Medical ablation system, using the PADN catheter and targeted radiofrequency delivery, allows denervation of the pulmonary artery and modulation of the activity of the sympathetic nervous system in the pulmonary region, with a positive impact on the patient’s hemodynamic conditions.

This advanced solution introduces a new paradigm in the clinical approach to pulmonary hypertension, significantly expanding the therapeutic possibilities for patients.

We offer a range of advanced solutions for the treatment of structural heart diseases, including percutaneous prostheses for native aortic insufficiency, closure systems for congenital defects, and left atrial appendage (LAA) closure devices. Additionally, we provide an implantable device designed to induce controlled narrowing of the coronary sinus for the treatment of refractory angina, ensuring minimally invasive interventions and optimal clinical outcomes.
Among our cutting-edge solutions for structural heart disease treatment, we offer innovative devices such as LAmbre™, CeraFlex™, and KONAR-MF™, all designed to ensure minimally invasive procedures and optimal clinical results.

Lifetech LAmbre™ Left Atrial Appendage Closure System: a percutaneous system designed to prevent thromboembolic stroke originating from the left atrial appendage in patients with non-valvular atrial fibrillation. It adapts to a wide range of appendage anatomies thanks to its double conformation and design: regular sizes for disc and umbrella and bigger sizes for disks with regular sizes for the umbrella. Multiple anchoring mechanisms ensure device stability.

Lifetech CeraFlex™ Occluder Series: a series of devices designed for percutaneous transcatheter closure of congenital heart defects and as a prevention therapy for cryptogenic strokes, such as atrial septal defect (ASD), Patent Foramen Ovale (PFO) and patent ductus arteriosus (PDA). The flexible design of its unique mechanism of wire loop connection between the occluder and the delivery cable facilitates implantation and enhances anatomical adaptation.

Lifetech KONAR-MF™ VSD Occluder: a device specifically designed for the percutaneous closure of ventricular septal defects (VSD), offering a minimally invasive treatment option for patients with this condition, that can be performed both in anterograde and retrograde way thanks to the presence of a connection hub for the delivery cable on the right and left disks of the occlude.

These state-of-the-art devices represent groundbreaking solutions in the field of structural heart interventions, significantly improving patient quality of life through safe and effective procedures.

Introducers

  • Femoral Introducers: devices for transfemoral vascular access.
  • RADIFOCUS™ Introducer II Mcoat™: radial introducer with hydrophilic coating to minimize friction and improve navigability. This technology enhances vascular navigation, ensuring smoother, safer, and more comfortable interventional procedures.
  • Slender: low-profile radial introducer designed for patients with small vessels.

Radial compression system

  • TR Band™: radial artery compression device for post-procedure hemostasis, with precise pressure control to ensure safety and patient comfort.

Diagnostic catheters

  • Optitorque™: high-performance coronary diagnostic catheter optimized for complex anatomies.
  • Outlook™: diagnostic catheter with excellent trackability and support.

Guiding catheters

  • Heartrail™: guiding catheter with robust, flexible structure for stable coronary support.
  • Climber™: guiding catheter designed to provide additional support in complex anatomies.

Coronary guidewires

  • Runthrough™: coronary guidewire balancing pushability and flexibility for complex interventions and tortuous vessels.

Coronary microcatheters

  • Finecross™ MG: coronary microcatheter combining high crossing ability and guidewire support, ideal for complex cases such as tortuous vessels, chronic total occlusions (CTO), and bifurcations.
  • Finecross™ M3: evolution of the MG with increased trackability and support.

PTCA balloons

  • Accuforce™: non-compliant PTCA balloon catheter offering optimal balance between high pressure and durability, ensuring accurate dilation and advanced deliverability for the treatment of complex coronary lesions.
  • Ryurei™: semi-compliant PTCA balloon catheter offering superior crossing capability thanks to a reduced distal profile and Terumo’s Mcoat™ hydrophilic coating, facilitating access to difficult lesions.

Aspiration catheter

  • Eliminate™: aspiration catheter for the removal of coronary thrombi.

Coronary stents

  • Ultimaster™ Tansei™: sirolimus-eluting stent with biodegradable polymer, optimized for coronary support and vascular healing.
  • Ultimaster™ Nagomi™: sirolimus-eluting coronary stent system with biodegradable polymer, designed to offer excellent conformability and optimal vessel support, improving clinical outcomes in patients undergoing percutaneous coronary interventions.

Among our advanced solutions, we include innovative devices such as Reducer, designed to ensure minimally invasive procedures and optimal clinical results.

Shockwave Reducer: a percutaneous, hourglass-shaped device that creates controlled narrowing of the coronary sinus, increasing retrograde pressure and improving myocardial perfusion in ischemic areas. This helps reduce symptoms of refractory angina, providing an effective, minimally invasive treatment option.

These state-of-the-art devices represent groundbreaking solutions in the field of structural heart interventions, significantly improving patient quality of life through safe and effective procedures.

We offer advanced mechanical thrombectomy systems for percutaneous treatment, ideal for safely and effectively treating deep vein thrombosis (DVT) and pulmonary embolism. Our solutions enable rapid thrombus removal, improving patient symptoms and their quality of life. Among our advanced percutaneous mechanical thrombectomy systems for treating pulmonary embolism and deep vein thrombosis, we offer devices such as FlowTriever and ClotTriever by Inari Medical:
  • FlowTriever System: A percutaneous device, designed for mechanical thrombus removal in pulmonary arteries, in a single session without the use of thrombolytics. It reduces the risk of bleeding and intensive care unit (ICU) stay times, and improving quickly the hemodynamics parameters.
  • ClotTriever System: a percutaneous device designed for mechanical thrombus removal in peripheral veins, indicated for deep vein thrombosis (DVT) treatment. It allows complete thrombus removal in a single session without the use of thrombolytics, rapidly improving symptoms and reducing the risk of long-term complications.
These devices offer effective options for managing thromboembolic diseases, contributing to better clinical outcomes and enhanced quality of life for patients.

Our mechanical circulatory support systems provide temporary cardiac assistance during or after complex cardiac procedures to prevent or treat hemodynamic instability or cardiogenic shock. These systems help stabilize the patient’s condition and improve cardiac function.

Among our solutions, the Impella CP® with SmartAssist® catheter is a percutaneous device that delivers up to 4.3 L/min additional blood flow to the circulation, making it ideal for patients in cardiogenic shock or at risk for hemodynamic instability, i.e. during high-risk PCI. The SmartAssist® technology enables continuous monitoring and optimal positioning.

  • Minimally invasive access

  • Immediate hemodynamic stability

  • Direct left-ventricular unloading

We offer an innovative therapeutic approach for the treatment of pulmonary hypertension. The Pulnovo® Medical ablation system, using the PADN catheter and targeted radiofrequency delivery, allows denervation of the pulmonary artery and modulation of the activity of the sympathetic nervous system in the pulmonary region, with a positive impact on the patient’s hemodynamic conditions.

This advanced solution introduces a new paradigm in the clinical approach to pulmonary hypertension, significantly expanding the therapeutic possibilities for patients.

We offer a range of advanced solutions for the treatment of structural heart diseases, including percutaneous prostheses for native aortic insufficiency, closure systems for congenital defects, and left atrial appendage (LAA) closure devices. Additionally, we provide an implantable device designed to induce controlled narrowing of the coronary sinus for the treatment of refractory angina, ensuring minimally invasive interventions and optimal clinical outcomes.
Among our cutting-edge solutions for structural heart disease treatment, we offer innovative devices such as LAmbre™, CeraFlex™, and KONAR-MF™, all designed to ensure minimally invasive procedures and optimal clinical results.

Lifetech LAmbre™ Left Atrial Appendage Closure System: a percutaneous system designed to prevent thromboembolic stroke originating from the left atrial appendage in patients with non-valvular atrial fibrillation. It adapts to a wide range of appendage anatomies thanks to its double conformation and design: regular sizes for disc and umbrella and bigger sizes for disks with regular sizes for the umbrella. Multiple anchoring mechanisms ensure device stability.

Lifetech CeraFlex™ Occluder Series: a series of devices designed for percutaneous transcatheter closure of congenital heart defects and as a prevention therapy for cryptogenic strokes, such as atrial septal defect (ASD), Patent Foramen Ovale (PFO) and patent ductus arteriosus (PDA). The flexible design of its unique mechanism of wire loop connection between the occluder and the delivery cable facilitates implantation and enhances anatomical adaptation.

Lifetech KONAR-MF™ VSD Occluder: a device specifically designed for the percutaneous closure of ventricular septal defects (VSD), offering a minimally invasive treatment option for patients with this condition, that can be performed both in anterograde and retrograde way thanks to the presence of a connection hub for the delivery cable on the right and left disks of the occlude.

These state-of-the-art devices represent groundbreaking solutions in the field of structural heart interventions, significantly improving patient quality of life through safe and effective procedures.